JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4976
CorMedix
CRMD
$567M
| $49K | ﹤0.01% |
+6,473
| New | +$50.8K |
2019 Q2
0 quarters
|
|
4977
Pure Cycle
PCYO
$260M
| $49K | ﹤0.01% |
4,702
+530
| +13% | +$5.3K |
2017 Q4
6 quarters
|
|
|
MSON
4978
DELISTED
Misonix Inc
MSON
| $49K | ﹤0.01% |
+2,020
| New | +$41.8K |
2019 Q2
0 quarters
|
|
|
PKD
4979
DELISTED
Parker Drilling Company
PKD
| $49K | ﹤0.01% |
+2,561
| New | +$50.2K |
2019 Q2
0 quarters
|
|
|
MSL
4980
DELISTED
Midsouth Bancorp, Inc.
MSL
| $49K | ﹤0.01% |
4,317
+668
| +18% | +$7.91K |
2015 Q4
14 quarters
|
|
|
MBTF
4981
DELISTED
MBT Financial Corporation
MBTF
| $49K | ﹤0.01% |
4,903
+3,411
| +229% | +$34.2K |
2016 Q1
13 quarters
|
|
|
ARDC
4982
Are Dynamic Credit Allocation Fund
ARDC
$271M
| $48K | ﹤0.01% |
3,170
| – | – |
2018 Q1
5 quarters
|
|
4983
Crawford & Co Class A
CRD.A
$608M
| $48K | ﹤0.01% |
4,544
-590
| -11% | -$5.38K |
2019 Q1
1 quarter
|
|
4984
EVI Industries
EVI
$248M
| $48K | ﹤0.01% |
1,248
+313
| +33% | +$11.6K |
2017 Q4
6 quarters
|
|
|
MRCC
4985
DELISTED
Monroe Capital Corp
MRCC
| $48K | ﹤0.01% |
+4,200
| New | +$50.3K |
2019 Q2
0 quarters
|
|
4986
NI Holdings
NODK
$308M
| $48K | ﹤0.01% |
2,621
+252
| +11% | +$4.29K |
2017 Q4
6 quarters
|
|
4987
Unity Bancorp
UNTY
$550M
| $48K | ﹤0.01% |
2,166
+281
| +15% | +$5.87K |
2017 Q4
6 quarters
|
|
|
PHAS
4988
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $48K | ﹤0.01% |
+3,769
| New | +$46.2K |
2019 Q2
0 quarters
|
|
|
AFMD
4989
DELISTED
Affimed
AFMD
| $47K | ﹤0.01% |
+1,654
| New | +$55.7K |
2019 Q2
0 quarters
|
|
|
BRT
4990
BRT Apartments
BRT
$252M
| $47K | ﹤0.01% |
3,580
-557
| -13% | -$7.6K |
2018 Q2
4 quarters
|
|
4991
BlueLinx
BXC
$590M
| $47K | ﹤0.01% |
2,456
+283
| +13% | +$6.46K |
2017 Q2
8 quarters
|
|
|
AGNT
4992
AGNT Inc
AGNT
$637M
| $47K | ﹤0.01% |
+8,762
| New | +$46.5K |
2019 Q2
0 quarters
|
|
4993
Rush Enterprises Class B
RUSHB
$6.62B
| $47K | ﹤0.01% |
4,276
+617
| +17% | +$7.27K |
2017 Q4
6 quarters
|
|
4994
ProShares UltraPro Short S&P 500
SPXU
$403M
| $47K | ﹤0.01% |
17
+3
| +21% | +$8.97K |
2018 Q4
2 quarters
|
|
|
STRS
4995
DELISTED
STRATUS PPTYS INC
STRS
| $47K | ﹤0.01% |
1,632
+190
| +13% | +$5.1K |
2016 Q4
10 quarters
|
|
4996
Biglari Holdings Class B
BH
$1.19B
| $46K | ﹤0.01% |
428
-3,964
| -90% | -$473K |
2016 Q3
11 quarters
|
|
4997
C&F Financial
CFFI
$323M
| $46K | ﹤0.01% |
903
-746
| -45% | -$37.2K |
2016 Q4
10 quarters
|
|
|
JPXN
4998
iShares JPX-Nikkei 400 ETF
JPXN
$142M
| $46K | ﹤0.01% |
792
| – | – |
2017 Q4
6 quarters
|
|
4999
KVH Industries
KVHI
$127M
| $46K | ﹤0.01% |
4,454
-277
| -6% | -$2.74K |
2017 Q4
6 quarters
|
|
5000
Rockwell Medical
RMTI
$33.4M
| $46K | ﹤0.01% |
139
+34
| +32% | +$17.3K |
2013 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.